A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder (Q46445206)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder |
scientific article |
Statements
1 reference
A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder (English)
1 reference
1 reference
William Steers
1 reference
Peggy Norton
1 reference
Richard Millard
1 reference
Georg Kralidis
1 reference
Karin Glavind
1 reference
Paul Abrams
1 reference
1 May 2005
1 reference
1 reference
95
1 reference
7
1 reference
993-1001
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference